Evidence map›Paper›PMID 39988621›Full record

ArticleCommunications biology2025

Author Correction: Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Rain R Chen, Mingo M H Yung, Yang Xuan, Shijie Zhan, Leanne L Leung, Rachel R Liang, Thomas H Y Leung, Huijuan Yang, Dakang Xu, Rakesh Sharma and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Rain R ChenThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China.
Mingo M H YungThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China.
Yang XuanThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China.
Shijie ZhanThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China.
Leanne L LeungThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China.
Rachel R LiangThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China.
Thomas H Y LeungDepartment of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.
Huijuan YangDepartment of Gynecological Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, P.R. China.
Dakang XuFaculty of Medical Laboratory Science, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P.R. China.
Rakesh SharmaProteomics & Metabolomics Core Facility, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.
Karen K L ChanDepartment of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.
Siew-Fei NguDepartment of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P. R. China.
Hextan Y S NganThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China. hysngan@hku.hk.
David W ChanThe University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen, P. R. China. dwchan@hku.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39988621
PMCPMC11847909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.